BI 1015550, NERANDOMILAST clinical trials

Relative bioavailability of two different formulations of nerandomilast and investigation of the food effect on new formulation following oral administration in healthy adult male and female subjects (an open-label, randomised, single-dose, three-way crossover trial)

This study looks at a new medicine called nerandomilast. We want to see how two different forms of this medicine are absorbed by the body. We'll also check if food changes how a new form of it works, helping us understand the best way to take it.